# Randomized, Double-Blind, Placebo-Controlled Trial of Nimodipine for the Neurological Manifestations of HIV-1

> **NCT00000738** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 36 (—)

## Conditions studied

- AIDS Dementia Complex
- HIV Infections

## Interventions

- **DRUG:** Nimodipine
- **DRUG:** Zidovudine

## Key facts

- **NCT ID:** NCT00000738
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 1994-06
- **Target enrollment:** 36 (—)
- **Last updated:** 2021-11-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000738

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000738, "Randomized, Double-Blind, Placebo-Controlled Trial of Nimodipine for the Neurological Manifestations of HIV-1". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00000738. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*